Scarica l'app Stockscreener
21.52
0.00%
0.00
Dopo l'orario di chiusura:
21.52
Xencor Inc Borsa (XNCR) Ultime notizie
Trading (XNCR) With Integrated Risk Controls - Stock Traders Daily
Xencor Doses First Subject in Phase 1/2 Study of XmAb®942 in Development for Patients with Inflammatory Bowel Disease - BioSpace
Please Don’t Call Me a ‘Genus’: The High Bar for Section 112 in the Unpredictable Arts as Illustrated by In re Xencor - IPWatchdog.com
Does Xencor (XNCR) Have the Potential to Rally 68.16% as Wall Street Analysts Expect? - Yahoo Finance
Xencor (XNCR) Expected to Beat Earnings Estimates: Should You Buy? - MSN
Xencor, Inc. (NASDAQ:XNCR) Given Average Rating of "Buy" by Brokerages - MarketBeat
Xencor, Inc. (NASDAQ:XNCR) Given Average Rating of “Buy” by Analysts - Defense World
How to Take Advantage of moves in (XNCR) - Stock Traders Daily
Essex LLC Takes Position in Xencor, Inc. (NASDAQ:XNCR) - MarketBeat
Creative Planning Sells 3,356 Shares of Xencor, Inc. (NASDAQ:XNCR) - Defense World
State Street Corp's Strategic Reduction in Xencor Inc Holdings - GuruFocus.com
Wall Street Analysts Predict a 67.2% Upside in Xencor (XNCR): Here's What You Should Know - Yahoo Finance
(XNCR) Pivots Trading Plans and Risk Controls - Stock Traders Daily
AQR Capital Management LLC Invests $753,000 in Xencor, Inc. (NASDAQ:XNCR) - MarketBeat
Xencor Insiders Sold US$891k Of Shares Suggesting Hesitancy - Simply Wall St
Xencor to begin human trials for bowel disease antibody - Investing.com
Xencor to begin human trials for bowel disease antibody By Investing.com - Investing.com Canada
Xencor Presents Preclinical Data on XmAb942, a High-Potency Extended Half-Life Anti-TL1A Antibody, to be Developed for Patients with Inflammatory Bowel Diseases - Business Wire
Blastic Plasmacytoid Dendritic Cell Neoplasm Market By The 2031 | Cellex Patient Treatment GmbH, AbbVie Inc, Xencor, Genentech, Inc, ImmunoGen, Inc – Times-BD24 - Times-BD24
Xencor board member to depart, company seeks new talent - Investing.com
Xencor board member to depart, company seeks new talent By Investing.com - Investing.com South Africa
Xencor Board Member Dagmar Rosa-Bjorkeson to Step Down - TipRanks
Xencor Announces Upcoming Change to Board of Directors - StockTitan
How To Trade (XNCR) - Stock Traders Daily
Xencor’s $175 Million Common Stock Underwritten Public Offering - Global Legal Chronicle
Point72 Asia Singapore Pte. Ltd. Buys New Shares in Xencor, Inc. (NASDAQ:XNCR) - Defense World
Dimensional Fund Advisors LP Has $27.63 Million Stock Holdings in Xencor, Inc. (NASDAQ:XNCR) - Defense World
Dimensional Fund Advisors LP Purchases 87,979 Shares of Xencor, Inc. (NASDAQ:XNCR) - MarketBeat
Analytical Overview: Xencor Inc (XNCR)’s Ratios Tell a Financial Story - The Dwinnex
Monitoring Xencor Inc (XNCR) after recent insider movements - Knox Daily
Xencor executive sells over $54k in company stock - Investing.com India
Xencor director Richard Ranieri sells over $50k in company stock - Investing.com India
Xencor executive sells over $54k in company stock By Investing.com - Investing.com Australia
Xencor executive sells over $50k in company stock - Investing.com India
Xencor executive Dagmar Rosa-Bjorkeson sells shares worth over $51k - Investing.com
Xencor executive sells over $50k in company stock By Investing.com - Investing.com Canada
Cubist Systematic Strategies LLC Reduces Holdings in Xencor, Inc. (NASDAQ:XNCR) - Defense World
Xencor, Inc. (NASDAQ:XNCR) Given Consensus Recommendation of "Buy" by Brokerages - MarketBeat
Xencor, Inc. (NASDAQ:XNCR) Receives Average Recommendation of “Buy” from Analysts - Defense World
Xencor, Inc. (NASDAQ:XNCR) Position Boosted by American Century Companies Inc. - Defense World
Xencor's SWOT analysis: biotech stock's potential in protein engineering - Investing.com
XTX Topco Ltd Acquires New Shares in Xencor, Inc. (NASDAQ:XNCR) - Defense World
Point72 Asset Management L.P. Increases Stock Position in Xencor, Inc. (NASDAQ:XNCR) - Defense World
Short Interest in Xencor, Inc. (NASDAQ:XNCR) Increases By 24.8% - MarketBeat
Point72 Asia Singapore Pte. Ltd. Acquires New Position in Xencor, Inc. (NASDAQ:XNCR) - Defense World
2.02%
0.47%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Capitalizzazione:
|
Volume (24 ore):